Paper Proffered Program Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Initial Tests for a Wrist-Based Quantitative PET Scanner: Flow Rates, Activity, Geometry, and Scatter

Abstract
Purpose

To identify and characterize how blood flow, activity concentration, geometry, and scatter affect the counting abilities of a prototype device to quantitatively measure PET radiotracer blood input function at the wrist.

Methods

A model system for measuring FDG in the wrist was constructed using 0.7 mm tubing and two sodium iodide detectors. A syringe autoinjector controlled the flow of FDG through the tubing at various rates (400 – 800 mL/min for a 1 mm syringe) to model blood flow. Spectra were collected in 10 second intervals over three minutes. Performance at different activity levels was also assessed. Scatter was modeled by passing the tubing through an acrylic cylinder; spectra with and without the acrylic scatterer were compared. Statistical analysis was performed in MATLAB.

Results

Performance was assessed in each trial by summing counts in each spectrum and comparing measured count rates to expected count rates. Regression analysis found no significant correlation between peak counts and blood flow (R2 = 0.169), which was confirmed with ANOVA (p-value = 0.492), but did find that the count rate as a percentage of expected rate was correlated with the blood flow (R2 = 0.828, ANOVA p-value = 0.032). Scatter increased counts by more than 15% compared to the absence of scattering material. Counts in spectra scaled as expected with activity.

Conclusion

This work demonstrated the factors that must be considered to dynamically measure PET tracer in the wrist for quantitative modeling of tracer uptake. Blood flow rate, scatter, and activity concentration all influence the relative measured count rate as compared to true count rate, indicating that the proper quantitation from this system must account for these factors.

People

Related

Similar sessions

Poster Poster Program
Jul 19 · 07:00
Adverse Events in Targeted Radionuclide Therapy

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

Harrison L. Agordzo
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Development of a Web-Based Theranostic Workflow Management Tool

To develop a Web-Based Theranostic Workflow Management Tool (TWMT) to efficiently manage Theranostic program in the department of radiation oncology (RadOnc).

Ling Zhuang, PhD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Epidseg-Net:the Multi-Modal Fusion Framework Based on Drr Guidance In Radiotherapy Is Used for Precise Segmentation of Epid Lung Targets

The proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture featu...

Huang Qian Qianjia, M.Eng
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested